Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sherven Sharma

Showing results (51-60 of 103) with videos related to

Pageof 11
Sort By:
Autoimmunity Reviews|August 26, 2014
Th17 cells in inflammation and autoimmunityRam Pyare Singh, Sascha Hasan, Sherven Sharma, et al.
BMC Cancer|March 18, 2014
Role of PAX8 in the regulation of MET and RON receptor tyrosine kinases in non-small cell lung cancerRajani Kanteti, Essam El-Hashani, Immanuel Dhanasingh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2011
Role of CXCR3 ligands in IL-7/IL-7R alpha-Fc-mediated antitumor activity in lung cancerAsa Andersson, Minu K Srivastava, Marni Harris-White, et al.
Molecular Cancer|November 14, 2003
Overexpression of CCL-21/secondary lymphoid tissue chemokine in human dendritic cells augments chemotactic activities for lymphocytes and antigen presenting cellsKaren Riedl, Felicita Baratelli, Raj K Batra, et al.
Cancer Research|September 18, 2004
Cyclooxygenase-2 modulates the insulin-like growth factor axis in non-small-cell lung cancerMehis Põld, Kostyantyn Krysan, Anu Põld, et al.
Plos One|May 12, 2011
Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growthUpendra K Kar, Minu K Srivastava, Asa Andersson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2005
Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cellsFelicita Baratelli, Ying Lin, Li Zhu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2008
Inflammation, epithelial to mesenchymal transition, and epidermal growth factor receptor tyrosine kinase inhibitor resistanceKostyantyn Krysan, Jay M Lee, Mariam Dohadwala, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
EBV-induced molecule 1 ligand chemokine (ELC/CCL19) promotes IFN-gamma-dependent antitumor responses in a lung cancer modelSven Hillinger, Seok-Chul Yang, Li Zhu, et al.
Clinical Lung Cancer|August 16, 2005
Chemoprevention strategies with cyclooxygenase-2 inhibitors for lung cancerJenny T Mao, Xiaoyan Cui, Karen Reckamp, et al.
Pageof 11

Showing results (51-60 of 103) with videos related to

Sort By:
Pageof 11
Autoimmunity Reviews|August 26, 2014
Th17 cells in inflammation and autoimmunityRam Pyare Singh, Sascha Hasan, Sherven Sharma, et al.
BMC Cancer|March 18, 2014
Role of PAX8 in the regulation of MET and RON receptor tyrosine kinases in non-small cell lung cancerRajani Kanteti, Essam El-Hashani, Immanuel Dhanasingh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2011
Role of CXCR3 ligands in IL-7/IL-7R alpha-Fc-mediated antitumor activity in lung cancerAsa Andersson, Minu K Srivastava, Marni Harris-White, et al.
Molecular Cancer|November 14, 2003
Overexpression of CCL-21/secondary lymphoid tissue chemokine in human dendritic cells augments chemotactic activities for lymphocytes and antigen presenting cellsKaren Riedl, Felicita Baratelli, Raj K Batra, et al.
Cancer Research|September 18, 2004
Cyclooxygenase-2 modulates the insulin-like growth factor axis in non-small-cell lung cancerMehis Põld, Kostyantyn Krysan, Anu Põld, et al.
Plos One|May 12, 2011
Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growthUpendra K Kar, Minu K Srivastava, Asa Andersson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2005
Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cellsFelicita Baratelli, Ying Lin, Li Zhu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2008
Inflammation, epithelial to mesenchymal transition, and epidermal growth factor receptor tyrosine kinase inhibitor resistanceKostyantyn Krysan, Jay M Lee, Mariam Dohadwala, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2003
EBV-induced molecule 1 ligand chemokine (ELC/CCL19) promotes IFN-gamma-dependent antitumor responses in a lung cancer modelSven Hillinger, Seok-Chul Yang, Li Zhu, et al.
Clinical Lung Cancer|August 16, 2005
Chemoprevention strategies with cyclooxygenase-2 inhibitors for lung cancerJenny T Mao, Xiaoyan Cui, Karen Reckamp, et al.
Pageof 11